Hyphens Pharma International - Phillip Securities 2023-08-22: Year Of Investment & Challenges

Hyphens Pharma International - Year Of Investment & Challenges

Published:
Hyphens Pharma (SGX:1J5) | SGinvestors.ioHyphens Pharma (SGX:1J5)
  • - Read this at SGinvestors.io -
  • Hyphens Pharma announced a 3.6 cents special interim dividend for the 5th anniversary of its IPO.
  • Our DCF target price for Hyphens Pharma is lowered to S$0.35 (previously S$0.39). Our BUY recommendation is maintained.
  • The Positive

    Healthy balance sheet and special dividend

    • - Read this at SGinvestors.io -

    The Negative

    Weakness in specialty pharma.

    • Read more at SGinvestors.io.




    Above is the excerpt from report by Phillip Securities Research.
    Clients of Phillip Capital may be the first to access the full report in PDF @ https://www.stocksbnb.com/.




    Paul Chew Phillip Securities Research | https://www.stocksbnb.com/ 2023-08-22



    Read also Phillip's most recent report:
    2024-08-21 Hyphens Pharma International - New Products & Wider Distribution.

    Previous report by Phillip:
    2024-03-14 Hyphens Pharma International - More Visible Growth Drivers.

    Price targets by 2 other brokers at Hyphens Pharma Target Prices.

    Listing of research reports at Hyphens Pharma Analyst Reports.

    Relevant links:
    Hyphens Pharma Share Price History,
    Hyphens Pharma Announcements,
    Hyphens Pharma Dividends & Corporate Actions,
    Hyphens Pharma News Articles





    Advertisement

    You May Also Like




    SGX Stock / REIT Search

    Advertisement

    Most Read

    Trust Bank God Of Fortune Referral Code PGKPSWAE Trust Bank Referral Code 🎁

    Advertisement